Immunogenicity and safety of a Meningococcus B Brazilian vaccine

Completed

• Conditions: Meningococcus B disease; Infections and Infestations; Meningococcal infection

• Registration Number: ISRCTN15065741
• Lead Sponsor: Bio-Manguinhos/Fiocruz (Brazil)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03-27
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

1. Both sexes
2. Aged between 4 years and 12 years
3. Agreement with Free and Informed Consent Form
4. Healthy children

Exclusion Criteria

1. Personal history of meningitis or meningococcus B vaccine
2. Immunosupression
3. Use of blood products in the last 12 months
4. Use of penicillin in the last 30 days
5. Personal history of serious adverse event to any vaccination

Study & Design

• Study Type: Interventional
• Study Design: Not specified